Published in Clin Infect Dis on March 01, 1992
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis. JAMA (2016) 1.84
Contagious diseases in the United States from 1888 to the present. N Engl J Med (2013) 1.54
Major outbreak of pertussis in northern Alberta, Canada: analysis of discrepant direct fluorescent-antibody and culture results by using polymerase chain reaction methodology. J Clin Microbiol (1993) 1.39
Rapid immunodot technique for identifying Bordetella pertussis. J Clin Microbiol (1993) 1.13
Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide. Infect Immun (1994) 1.12
Diagnosis and management of pertussis. CMAJ (2005) 1.11
Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev (2016) 1.07
Molecular epidemiology of the pertussis epidemic in Washington State in 2012. J Clin Microbiol (2014) 1.07
Detection of Bordetella pertussis by rapid-cycle PCR and colorimetric microwell hybridization. J Clin Microbiol (1996) 0.99
Pertussis vaccination for health care workers. Clin Microbiol Rev (2008) 0.92
Recommendation for the use of newly introduced Tdap vaccine in Korea. Korean J Pediatr (2011) 0.91
Reproducibility of Bordetella pertussis genomic DNA fragments generated by XbaI restriction and resolved by pulsed-field gel electrophoresis. J Clin Microbiol (2002) 0.91
Long-lived respiratory immune response to filamentous hemagglutinin following Bordetella pertussis infection. Infect Immun (1993) 0.90
The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study. BMC Infect Dis (2013) 0.88
Unexpected isolation of Bordetella pertussis from a blood culture. J Clin Microbiol (1994) 0.81
Active immunization in the United States: developments over the past decade. Clin Microbiol Rev (2001) 0.80
Adolescent and adult pertussis. A problem and a solution. Can Fam Physician (2000) 0.78
Prevention of pertussis through adult vaccination. Hum Vaccin Immunother (2015) 0.76
Pertussis post-exposure prophylaxis among household contacts: a cost-utility analysis. PLoS One (2015) 0.76
Patterns of susceptibility in an outbreak of Bordetella pertussis: evidence from a community-based study. Can J Infect Dis (2002) 0.75
Effect of Basti (oil enema) therapy for the management of cough in pertussis. Ayu (2013) 0.75
The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis. F1000Res (2017) 0.75
Pasteurized milk as a vehicle of infection in an outbreak of listeriosis. N Engl J Med (1985) 11.94
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med (2000) 8.05
Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. JAMA (2001) 4.90
A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med (1996) 4.86
Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA (1993) 4.63
Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA (1985) 3.85
Morbidity and mortality associated with the July 1980 heat wave in St Louis and Kansas City, Mo. JAMA (1982) 3.69
Cost-effectiveness of a routine varicella vaccination program for US children. JAMA (1994) 3.27
Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA (1991) 3.09
Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis. N Engl J Med (1995) 2.81
Risk factors for delayed immunization in a random sample of 1163 children from Oregon and Washington. Pediatrics (1993) 2.74
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (2001) 2.40
Nutritional status of children in Nepal, 1975. Bull World Health Organ (1976) 2.34
Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA (1987) 2.28
Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics (1997) 2.25
Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet (1993) 2.24
Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin Infect Dis (1993) 2.21
Human monkeypox. Bull World Health Organ (1972) 2.18
Laboratory diagnosis of pertussis: the state of the art. Pediatr Infect Dis J (1987) 2.13
Continuing measles transmission in students despite school-based outbreak control program. Am J Epidemiol (1985) 2.09
The Vaccine Adverse Event Reporting System (VAERS). Vaccine (1994) 2.02
The health and economic burden of cigarette smoking in Georgia in 1985. J Med Assoc Ga (1989) 1.94
Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA (1996) 1.93
Risk factors for outbreaks of influenza in nursing homes. A case-control study. Am J Epidemiol (1986) 1.93
Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. JAMA (1985) 1.91
Azithromycin prophylaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia. J Infect Dis (2001) 1.85
Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. N Engl J Med (1990) 1.82
Acquired immunodeficiency syndrome in low-incidence areas. How safe is unsafe sex? JAMA (1987) 1.81
Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med (1994) 1.79
Outbreaks in highly vaccinated populations: implications for studies of vaccine performance. Am J Epidemiol (1994) 1.77
Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting. JAMA (1992) 1.74
The case for global eradication of poliomyelitis. Bull World Health Organ (1987) 1.72
Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine. A population-based case-control study. JAMA (1994) 1.71
Health impact of measles vaccination in the United States. Pediatrics (1985) 1.71
Practical experiences in obtaining informed consent for a vaccine trial in rural Africa. N Engl J Med (1997) 1.67
Efficacy of whole-cell pertussis vaccine in preschool children in the United States. JAMA (1992) 1.60
Childhood upper respiratory tract infections: to what degree is incidence affected by day-care attendance? Pediatrics (1987) 1.57
An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease. Am J Epidemiol (1989) 1.53
Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med (1981) 1.52
Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child. Am J Epidemiol (1984) 1.47
Comment: ethical dilemmas in worldwide polio eradication programs. Am J Public Health (1997) 1.44
Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes. Antimicrob Agents Chemother (1984) 1.42
Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. J Pediatr (1986) 1.40
Evaluation of telephoned computer-generated reminders to improve immunization coverage at inner-city clinics. Public Health Rep (1993) 1.40
Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination. Clin Infect Dis (1998) 1.38
A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 1.37
Pneumonic tularemia on Martha's Vineyard. N Engl J Med (1979) 1.36
Obstacles to achieving immunization for all 2000: missed immunization opportunities and inappropriately timed immunization. J Trop Pediatr (1991) 1.34
Preparing for pandemic influenza: the need for enhanced surveillance. Emerg Infect Dis (1999) 1.32
Risk factors for community- and household-acquired pertussis during a large-scale outbreak in central Wisconsin. J Infect Dis (1988) 1.31
Mumps outbreak in a highly vaccinated population. J Pediatr (1991) 1.30
Potential impact on vaccination coverage levels by administering vaccines simultaneously and reducing dropout rates. Arch Pediatr Adolesc Med (1994) 1.28
Current poliomyelitis immunization policy in the United States. Pediatr Ann (1990) 1.28
Vaccine prevention of Haemophilus influenzae type b disease: past, present and future. Pediatr Infect Dis (1986) 1.27
Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J Pediatr (1998) 1.27
Determinants of vaccination in an urban population in Conakry, Guinea. Int J Epidemiol (1991) 1.25
Pertussis epidemic in Oklahoma. Difficulties in preventing transmission. Am J Dis Child (1986) 1.23
Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med (1994) 1.23
Microtiter determination of measles hemagglutination inhibition antibody with filter papers. J Clin Microbiol (1983) 1.22
Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol (1994) 1.20
Measles among the Amish: a comparative study of measles severity in primary and secondary cases in households. J Infect Dis (1991) 1.20
Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979-1984. Am J Epidemiol (1990) 1.18
Disease eradication as a public health strategy: a case study of poliomyelitis eradication. Bull World Health Organ (2000) 1.18
A randomized controlled trial of influenza vaccine in the elderly. Scientific scrutiny and ethical responsibility. JAMA (1994) 1.17
A cluster of Acinetobacter Pneumonia in foundry workers. Ann Intern Med (1981) 1.16
Mumps transmission in hospitals. Arch Intern Med (1990) 1.14
Use of influenza vaccine in nursing homes. J Am Geriatr Soc (1985) 1.14
Use of IgM-hepatitis A antibody testing. Investigating a common-source, food borne outbreak. JAMA (1981) 1.13
Defining delayed immunization. Pediatr Infect Dis J (1993) 1.13
Principles of measles control. Bull World Health Organ (1991) 1.13
The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med (1988) 1.12
National immunization days: state of the art. J Infect Dis (1997) 1.12
Measles eradication: is it in our future? Am J Public Health (2000) 1.12
Preventing rubella: assessing missed opportunities for immunization. Am J Public Health (1987) 1.11
Tetanus surveillance--United States, 1989-1990. MMWR CDC Surveill Summ (1992) 1.09
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol (1994) 1.09
The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis (1997) 1.08
A large outbreak of mumps in the postvaccine era. J Infect Dis (1988) 1.08
Mumps in the workplace. Further evidence of the changing epidemiology of a childhood vaccine-preventable disease. JAMA (1988) 1.07
Kawasaki syndrome: association with the application of rug shampoo. Lancet (1982) 1.06
Live or inactivated poliomyelitis vaccine: an analysis of benefits and risks. Am J Public Health (1988) 1.06
Forty years and four surveys: how does our measuring measure up? Am J Prev Med (2001) 1.06
Immunizations in college health: the remaining tasks. J Am Coll Health (1987) 1.06
Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team. Pediatrics (1996) 1.06
Infant mortality and childhood nutritional status among Afghan refugees in Pakistan. Int J Epidemiol (1987) 1.05
Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis (1991) 1.04
A randomized trial of the effectiveness of computer-generated telephone messages in increasing immunization visits among preschool children. Arch Pediatr Adolesc Med (1994) 1.04